Cite
APA Citation
Beatty, G. L., Shahda, S., Beck, T., Uppal, N., Cohen, S. J., Donehower, R., Gabayan, A. E., Assad, A., Switzky, J., Zhen, H., & Von Hoff, D. D. (2019). a Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors. Oncologist, 24, 14–e10. http://access.bl.uk/ark:/81055/vdc_100076779423.0x000025